Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.

Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.

Item
http://www.wikidata.org/entity/Q46091778
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerIntra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and MetastasisDetection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate CancerMUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cellsHepatitis B virus X protein influences enrichment profiles of H3K9me3 on promoter regions in human hepatoma cell linesThe androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell ViabilityThe role of glycans in the development and progression of prostate cancer.shRNA-mediated downregulation of α-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell lines.Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia.
P2860

Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.

Item
http://www.wikidata.org/entity/Q46091778
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@en
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@nl
type
label
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@en
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@nl
prefLabel
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@en
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Increased expression of GCNT1 ...... UC1 in human prostate cancers.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932